Home > Adults > Haematology >

Guidelines for Primary Care

Checked: 24-08-2022 by Vicky Ryan Next Review: 23-08-2023

Clinical Guidance

BNSSG Guidelines

Please see the Primary Care Guidelines Document (PDF) before considering referral to haematology at UHBW or NBT:

GP Haematology Guidelines

These guidelines are gradually being updated and added to Remedy as individual pages in the Haematology section. You will be redirected to the page as appropriate.

Haematology in Primary Care

GPs may also like to review these Haematology in Primary Care slides which were used in an educational webinar held on 19/06/19 and include B12, Anaemia, Platelets - Thrombocythaemia, Thrombocytopenia, Lymphopenia. Please use with caution as some of the information on the slides may have been since been updated elsewhere.

Haematology Oncology - SWCN

The South West Clinical Network has created a set of documents which are available on the SWCN website providing supporting information for General Practitioners referring to Haematology Oncology services. These are living documents that will be continually reviewed and updated, and are for information and guidance only.

Red Flags

Please see the Haematology - USC (2WW) page for advice on appropriate referrals for suspected haematological malignancy.

Referral

Consider the guidance above prior to requesting A and G or making a referral.

Advice and Guidance Referrals

Please see the Advice & Guidance Service page for details on accessing advice and guidance.

UHBW Referrals

Referrals should be made via eRS if indicated.

The following document is a guide to appropriate referrals:

UHBristol Haematology clinic referrals (not fulfilling the criteria for 2ww)

NBT Referrals

Referrals should be made via eRS if indicated.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.